Report Update Nov 1, 2024

ASEAN - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights

Single report

Sent by email within 24h (Mon-Fri)

$599 Basic Edition

$2095 Professional Edition

What's the difference?

Subscription

Online access and download

from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

ASEAN: Medicaments Containing Insulin Market 2024

Medicaments Containing Insulin Market Size in ASEAN

The ASEAN medicaments containing insulin market was finally on the rise to reach $X in 2021, after three years of decline. Overall, consumption, however, saw a abrupt descent. The level of consumption peaked at $X in 2013; however, from 2014 to 2021, consumption remained at a lower figure.

Medicaments Containing Insulin Production in ASEAN

In value terms, medicaments containing insulin production contracted to $X in 2021 estimated in export price. In general, production, however, recorded a abrupt downturn. The most prominent rate of growth was recorded in 2013 when the production volume increased by 28%. As a result, production attained the peak level of $X. From 2014 to 2021, production growth failed to regain momentum.

Medicaments Containing Insulin Exports

Exports in ASEAN

In 2021, after five years of growth, there was significant decline in shipments abroad of medicaments containing insulin but not antibiotics, when their volume decreased by -33.1% to X tons. Overall, exports, however, recorded a significant expansion. The most prominent rate of growth was recorded in 2016 when exports increased by 181% against the previous year. Over the period under review, the exports hit record highs at X tons in 2020, and then fell remarkably in the following year.

In value terms, medicaments containing insulin exports contracted remarkably to $X in 2021. In general, exports, however, enjoyed a significant expansion. The most prominent rate of growth was recorded in 2016 when exports increased by 584% against the previous year. Over the period under review, the exports hit record highs at $X in 2020, and then fell remarkably in the following year.

Exports by Country

The shipments of the one major exporters of medicaments containing insulin but not antibiotics, namely Thailand, represented more than two-thirds of total export.

Thailand was also the fastest-growing in terms of the medicaments containing insulin but not antibiotics exports, with a CAGR of +102.4% from 2012 to 2021. While the share of Thailand (+93 p.p.) increased significantly, the shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Thailand ($X) also remains the largest medicaments containing insulin supplier in ASEAN.

In Thailand, medicaments containing insulin exports increased at an average annual rate of +48.3% over the period from 2012-2021.

Export Prices by Country

The export price in ASEAN stood at $X per ton in 2021, remaining stable against the previous year. Overall, the export price showed a abrupt setback. The pace of growth was the most pronounced in 2016 an increase of 143%. As a result, the export price reached the peak level of $X per ton. From 2017 to 2021, the export prices remained at a lower figure.

As there is only one major export destination, the average price level is determined by prices for Thailand.

From 2012 to 2021, the rate of growth in terms of prices for Thailand amounted to -26.8% per year.

Medicaments Containing Insulin Imports

Imports in ASEAN

In 2021, imports of medicaments containing insulin but not antibiotics in ASEAN shrank to X tons, with a decrease of -6.8% on 2020. In general, imports showed a abrupt contraction. The most prominent rate of growth was recorded in 2017 with an increase of 245%. Over the period under review, imports hit record highs at X tons in 2012; however, from 2013 to 2021, imports failed to regain momentum.

In value terms, medicaments containing insulin imports fell notably to $X in 2021. Over the period under review, imports saw a deep contraction. The growth pace was the most rapid in 2017 with an increase of 105%. Over the period under review, imports reached the maximum at $X in 2012; however, from 2013 to 2021, imports remained at a lower figure.

Imports by Country

Malaysia dominates imports structure, reaching X tons, which was near 95% of total imports in 2021. Myanmar (X tons) followed a long way behind the leaders.

Malaysia was also the fastest-growing in terms of the medicaments containing insulin but not antibiotics imports, with a CAGR of +2.0% from 2012 to 2021. Myanmar experienced a relatively flat trend pattern. Malaysia (+50 p.p.) significantly strengthened its position in terms of the total imports, while the shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Malaysia ($X) constitutes the largest market for imported medicaments containing insulin but not antibiotics in ASEAN, comprising 67% of total imports. The second position in the ranking was taken by Myanmar ($X), with a 29% share of total imports.

In Malaysia, medicaments containing insulin imports expanded at an average annual rate of +4.2% over the period from 2012-2021.

Import Prices by Country

The import price in ASEAN stood at $X per ton in 2021, dropping by -15.3% against the previous year. In general, the import price, however, continues to indicate a relatively flat trend pattern. The most prominent rate of growth was recorded in 2020 an increase of 41% against the previous year. The level of import peaked at $X per ton in 2016; however, from 2017 to 2021, import prices failed to regain momentum.

There were significant differences in the average prices amongst the major importing countries. In 2021, amid the top importers, the country with the highest price was Myanmar ($X per ton), while Malaysia amounted to $X per ton.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Myanmar (+17.9%).

Source: IndexBox Platform

This report provides an in-depth analysis of the medicaments containing insulin market in ASEAN. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

Prodcom 21201230 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale

Country coverage:

Brunei Darussalam
Cambodia
Indonesia
Malaysia
Myanmar
Philippines
Singapore
Thailand
Vietnam
Lao People's Democratic Republic

Data coverage:

Market volume and value
Per Capita consumption
Forecast of the market dynamics in the medium term
Production in ASEAN, split by region and country
Trade (exports and imports) in ASEAN
Export and import prices
Market trends, drivers and restraints
Key market players and their profiles

Reasons to buy this report:

Take advantage of the latest data
Find deeper insights into current market developments
Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

How to diversify your business and benefit from new market opportunities
How to load your idle production capacity
How to boost your sales on overseas markets
How to increase your profit margins
How to make your supply chain more sustainable
How to reduce your production and supply chain costs
How to outsource production to other countries
How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

1. INTRODUCTION

Making Data-Driven Decisions to Grow Your Business
1. REPORT DESCRIPTION
2. RESEARCH METHODOLOGY AND AI PLATFORM
3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
4. GLOSSARY AND SPECIFIC TERMS
2. EXECUTIVE SUMMARY

A Quick Overview of Market Performance
1. KEY FINDINGS
2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
3. MARKET OVERVIEW

Understanding the Current State of The Market and Its Prospects
1. MARKET SIZE
2. CONSUMPTION BY COUNTRY
3. MARKET FORECAST TO 2030
4. MOST PROMISING PRODUCT

Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO
1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
2. BEST-SELLING PRODUCTS
3. MOST CONSUMED PRODUCT
4. MOST TRADED PRODUCT
5. MOST PROFITABLE PRODUCT FOR EXPORT
5. MOST PROMISING SUPPLYING COUNTRIES

Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO
1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
2. TOP PRODUCING COUNTRIES
3. TOP EXPORTING COUNTRIES
4. LOW-COST EXPORTING COUNTRIES
6. MOST PROMISING OVERSEAS MARKETS

Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO
1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
2. TOP CONSUMING MARKETS
3. UNSATURATED MARKETS
4. TOP IMPORTING MARKETS
5. MOST PROFITABLE MARKETS
7. PRODUCTION

The Latest Trends and Insights into The Industry
1. PRODUCTION VOLUME AND VALUE
2. PRODUCTION BY COUNTRY
8. IMPORTS
The Largest Importers on The Market and How They Succeed
1. IMPORTS FROM 2012–2023
2. IMPORTS BY COUNTRY
3. IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Exporters on The Market and How They Succeed
1. EXPORTS FROM 2012–2023
2. EXPORTS BY COUNTRY
3. EXPORT PRICES BY COUNTRY
10. PROFILES OF MAJOR PRODUCERS

The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO
11. COUNTRY PROFILES

The Largest Markets And Their Profiles
This Chapter is Available Only for the Professional Edition PRO
- Brunei Darussalam
- Cambodia
- Indonesia
- Malaysia
- Myanmar
- Philippines
- Singapore
- Thailand
- Vietnam
- Lao People's Democratic Republic
LIST OF TABLES
1. Key Findings In 2023
2. Market Volume, In Physical Terms, 2012–2023
3. Market Value, 2012–2023
4. Per Capita Consumption, By Country, 2018–2023
5. Production, In Physical Terms, By Country, 2012–2023
6. Imports, In Physical Terms, By Country, 2012–2023
7. Imports, In Value Terms, By Country, 2012–2023
8. Import Prices, By Country Of Destination, 2012–2023
9. Exports, In Physical Terms, By Country, 2012–2023
10. Exports, In Value Terms, By Country, 2012–2023
11. Export Prices, By Country Of Origin, 2012–2023
LIST OF FIGURES
1. Market Volume, In Physical Terms, 2012–2023
2. Market Value, 2012–2023
3. Consumption, By Country, 2023
4. Market Volume Forecast to 2030
5. Market Value Forecast to 2030
6. Products: Market Size And Growth, By Type
7. Products: Average Per Capita Consumption, By Type
8. Products: Exports And Growth, By Type
9. Products: Export Prices And Growth, By Type
10. Production Volume And Growth
11. Exports And Growth
12. Export Prices And Growth
13. Market Size And Growth
14. Per Capita Consumption
15. Imports And Growth
16. Import Prices
17. Production, In Physical Terms, 2012–2023
18. Production, In Value Terms, 2012–2023
19. Production, By Country, 2023
20. Production, In Physical Terms, By Country, 2012–2023
21. Imports, In Physical Terms, 2012–2023
22. Imports, In Value Terms, 2012–2023
23. Imports, In Physical Terms, By Country, 2023
24. Imports, In Physical Terms, By Country, 2012–2023
25. Imports, In Value Terms, By Country, 2012–2023
26. Import Prices, By Country, 2012–2023
27. Exports, In Physical Terms, 2012–2023
28. Exports, In Value Terms, 2012–2023
29. Exports, In Physical Terms, By Country, 2023
30. Exports, In Physical Terms, By Country, 2012–2023
31. Exports, In Value Terms, By Country, 2012–2023
32. Export Prices, 2012–2023